Lundquist Kevin Michael
SEC insider (Form 3/4/5 filer). CIK 0002074701. Chief Financial Officer at Outlook Therapeutics, Inc. (OTLK) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 1, 2026. Located in ISELIN, NJ.
Companies Lundquist Kevin Michael has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Officer, Chief Financial Officer
- CapsoVision, Inc (CV): Officer, Chief Financial Officer
Lundquist Kevin Michael
CIK: 0002074701
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
